Acadia Pharmaceuticals (ACAD) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 20.65% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02% |
| Dec 31, 2025 | -2.80% |
| Sep 30, 2025 | -10.38% |
| Jun 30, 2025 | -11.25% |
| Mar 31, 2025 | -8.72% |
| Dec 31, 2024 | -6.73% |
| Sep 30, 2024 | 18.95% |
| Jun 30, 2024 | -10.67% |
| Mar 31, 2024 | 3.81% |
| Dec 31, 2023 | -5.26% |
| Sep 30, 2023 | -4.63% |
| Jun 30, 2023 | -8.07% |
| Mar 31, 2023 | -13.02% |
| Dec 31, 2022 | -9.99% |
| Sep 30, 2022 | -5.97% |
| Jun 30, 2022 | 0.15% |
| Mar 31, 2022 | -9.04% |
| Dec 31, 2021 | -14.21% |
| Sep 30, 2021 | -8.31% |
| Jun 30, 2021 | 2.30% |
| Mar 31, 2021 | -13.60% |
| Dec 31, 2020 | -1.26% |
| Sep 30, 2020 | 2.76% |
| Jun 30, 2020 | 2.26% |
| Mar 31, 2020 | 12.80% |
| Dec 31, 2019 | 8.63% |
| Sep 30, 2019 | 16.28% |
| Jun 30, 2019 | 13.73% |
| Mar 31, 2019 | 18.48% |
| Dec 31, 2018 | 31.84% |
| Sep 30, 2018 | 29.60% |
| Jun 30, 2018 | 39.94% |
| Mar 31, 2018 | 12.06% |
| Dec 31, 2017 | 67.99% |
| Sep 30, 2017 | 143.88% |
| Jun 30, 2017 | 61.89% |
| Mar 31, 2017 | 70.13% |
| Dec 31, 2016 | 92.13% |
| Sep 30, 2016 | 126.79% |
| Jun 30, 2016 | 132.83% |
| Mar 31, 2016 | 173.87% |
| Dec 31, 2015 | 152.80% |
| Sep 30, 2015 | 166.77% |
| Jun 30, 2015 | 150.34% |
| Mar 31, 2015 | 227.66% |
| Dec 31, 2014 | 124.96% |
| Sep 30, 2014 | 50.17% |
| Jun 30, 2014 | 118.36% |
| Mar 31, 2014 | 103.54% |
| Dec 31, 2013 | 86.34% |
| Sep 30, 2013 | 108.24% |